Overview

Phase III Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs

Status:
Completed
Trial end date:
2018-10-27
Target enrollment:
Participant gender:
Summary
Phase III, multinational, multicentre, randomized, prospective, double blind, parallel groups, placebo-controlled study to evaluate the analgesic effects of Test Diclofenac Sodium 140mg medicated plaster, Reference DIEP 180 mg medicated plaster, Flector® and Placebo plaster in patients with painful and phlogistic disease due to acute traumatic events of the limbs.
Phase:
Phase 3
Details
Lead Sponsor:
Fidia Farmaceutici s.p.a.
Treatments:
Diclofenac
Diclofenac hydroxyethylpyrrolidine